Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Costs & Expenses

$39.93M

TTM · Period ending: · USD

LCTX logo

LCTX Total Costs & Expenses

Latest reported$39.93M
LCTX TTM Total Costs & Expenses ($1.30M → $39.93M)
High-resolution chart · PNG

LCTX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
39,933,000
52,486,000
51,175,000
45,997,000
46,149,000
30,879,000
30,977,000
31,449,000
31,781,000
32,755,000
33,678,000
33,782,000
34,080,000
34,618,000
37,223,000
57,867,000
58,663,000
57,397,000
53,107,000
29,957,000
27,979,000
26,959,000
27,220,000
28,876,000
30,448,000
35,018,000
40,354,000
42,928,000
44,910,000
43,589,000
42,411,000
42,265,000
41,620,000
42,569,000
42,448,000
44,327,000
44,296,000
48,506,000
61,209,000
71,453,000
79,452,000
78,611,000
68,334,638
60,928,433
55,665,545
55,125,885
52,687,066
50,933,330
49,007,802
44,118,758
41,393,995
35,875,435
32,069,960
30,543,659
28,187,089
27,701,957
26,127,267
24,750,819
23,053,849
21,136,431
19,034,000
16,293,155
13,535,888
7,377,437
7,485,783
6,029,821
5,144,570
7,382,375
5,341,825
5,161,984
4,742,076
4,104,691
3,150,732
2,295,372
2,268,612
2,472,899
2,692,560
2,972,396
2,913,879
2,778,096
2,815,742
2,707,815
2,921,611
3,028,523
2,970,729
2,937,562
2,657,151
2,492,400
2,373,254
2,320,144
2,246,250
2,411,798
2,348,046
2,391,975
2,421,649
2,115,341
2,682,406
3,203,690
3,602,601
4,209,603
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.